» Articles » PMID: 9370937

Identification of Specific Recognition Molecules on Murine Mononuclear Phagocytes and B Lymphocytes for Vi Capsular Polysaccharide: Modulation of MHC Class II Expression on Stimulation with the Polysaccharide

Overview
Journal Immunology
Date 1997 Nov 26
PMID 9370937
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Vi bacterial polysaccharide is a homopolymer of alpha 1-4 N-acetyl polygalacturonic acid with variable O-acetylation at position C-3 and forms a capsule around many bacteria. It has been referred to as the virulence factor of Salmonella typhi and is also a candidate vaccine against typhoid fever. The present study reports the interaction of this polysaccharide with murine mononuclear phagocytes and lymphocytes, and with human monocytes. Vi showed a dose-dependent binding to the murine monocyte cell lines WEHI-274.1 and J774. This binding was abrogated if the polysaccharide was deacetylated, suggesting involvement of acetyl groups in this interaction. Vi also bound to the murine B-cell lymphoma line A20, to peritoneal exudate cells and to a lesser degree to spleen cells and thymocytes from BALB/c mice. The polysaccharide also interacted with the human histiocytic lymphoma line U937 but not with the human monocyte cell line THP-1. Stimulation with Vi led to up-regulation of surface major histocompatibility complex (MHC) class II expression on A20 cells. Immunoprecipitation of Vi-bound molecules from cell surface biotinylated A20 and WEHI-274.1 revealed two bands with MW of about 32,000 and 36,000. The study demonstrates that Vi capsular polysaccharide can interact with mononuclear phagocytes and lymphocytes through specific cell surface molecules and modulate MHC class II expression.

Citing Articles

Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis.

Raffatellu M, Chessa D, Wilson R, Tukel C, Akcelik M, Baumler A Infect Immun. 2005; 74(1):19-27.

PMID: 16368953 PMC: 1346610. DOI: 10.1128/IAI.74.1.19-27.2006.


Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses.

Sharma A, Qadri A Proc Natl Acad Sci U S A. 2004; 101(50):17492-7.

PMID: 15576509 PMC: 536020. DOI: 10.1073/pnas.0407536101.


Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes.

Forestier C, Moreno E, Meresse S, Phalipon A, Olive D, Sansonetti P Infect Immun. 1999; 67(8):4048-54.

PMID: 10417173 PMC: 96700. DOI: 10.1128/IAI.67.8.4048-4054.1999.

References
1.
Hornick R, GREISMAN S, WOODWARD T, DuPont H, Dawkins A, Snyder M . Typhoid fever: pathogenesis and immunologic control. N Engl J Med. 1970; 283(13):686-91. DOI: 10.1056/NEJM197009242831306. View

2.
BAKER E, Whiteside R, Basch R, Derow M . The VI antigens of the Enterobacteriaceae. I. Purification and chemical properties. J Immunol. 1959; 83:680-96. View

3.
Sundstrom C, Nilsson K . Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer. 1976; 17(5):565-77. DOI: 10.1002/ijc.2910170504. View

4.
Szewczyk B, Taylor A . Immunochemical properties of Vi antigen from Salmonella typhi Ty2: presence of two antigenic determinants. Infect Immun. 1980; 29(2):539-44. PMC: 551152. DOI: 10.1128/iai.29.2.539-544.1980. View

5.
Rajagopalan P, Kumar R, Malaviya A . Immunological studies in typhoid fever. II. Cell-mediated immune responses and lymphocyte subpopulations in patients with typhoid fever. Clin Exp Immunol. 1982; 47(2):269-74. PMC: 1536530. View